aminoimidazole carboxamide has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, XJ; Chen, X; Qian, HY; Sun, YZ; Wu, R; Xu, GY; Zhang, PA; Zhu, HY | 1 |
1 other study(ies) available for aminoimidazole carboxamide and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Metformin attenuates diabetic neuropathic pain via AMPK/NF-κB signaling pathway in dorsal root ganglion of diabetic rats.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Spinal; Hyperalgesia; Hypoglycemic Agents; Male; MAP Kinase Signaling System; Metformin; Neuralgia; NF-kappa B; Rats; Rats, Sprague-Dawley; Ribonucleotides | 2021 |